| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6240803 | Journal of Cystic Fibrosis | 2013 | 4 Pages |
Abstract
Gaseous nitric oxide (NO) is bactericidal in vitro. However whether and how it can be used for the treatment of bacterial lung infections in patients with cystic fibrosis is unclear. Here we assessed the bactericidal effect of intermittently inhaled 160Â ppm NO for 30Â min every 4Â h in a Pseudomonas aeruginosa pneumonia model in rats. NO significantly reduced P. aeruginosa colony count in rat lungs but did not affect neutrophil myeloperoxidase function methemoglobin percentage nor plasma nitrite/nitrate levels. This regimen warrants exploration in infected patients with cystic fibrosis.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Christopher C. Miller, Christopher A. Hergott, Marta Rohan, Kyle Arsenault-Mehta, Gerd Döring, Sanjay Mehta,
